Modulators of alpha-synuclein toxicity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2608198

Disclosed are genes that, when overexpressed in cells expressing alpha- synuclein, either suppress or enhance alpha-synuclein mediated cellular toxicity. Compounds that modulate expression of these genes or activity of the encoded proteins can be used to inhibit alpha-synuclein mediated toxicity and used to treat or prevent synucleinopathies such as Parkinson's disease. Also disclosed are methods of identifying inhibitors of alpha- synuclein mediated toxicity.

L'invention concerne des gènes qui, lorsqu'ils sont surexprimés dans des cellules exprimant l'alpha-synucléine, soit éliminent soit augmentent la toxicité cellulaire induite par l'alpha-synucléine. Des composés modulant l'expression de ces gènes ou l'activité des protéines codées peuvent être utilisés pour inhiber la toxicité induite par l'alpha-synucléine et pour traiter ou prévenir des synucléinopathies, telles que la maladie de Parkinson. L'invention concerne en outre des méthodes d'identification d'inhibiteurs de la toxicité induite par l'alpha-synucléine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulators of alpha-synuclein toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of alpha-synuclein toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of alpha-synuclein toxicity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1602669

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.